These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37500336)

  • 1. Quantitative image features of gadoxetic acid-enhanced MRI for predicting glypican-3 expression of small hepatocellular carcinoma ≤3 cm.
    Dong SY; Sun W; Xu B; Wang WT; Yang YT; Chen XS; Zeng MS; Rao SX
    Clin Radiol; 2023 Oct; 78(10):e764-e772. PubMed ID: 37500336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging and diffusion-weighted imaging-based histogram analyses in predicting glypican 3-positive hepatocellular carcinoma.
    Zhao J; Gao S; Sun W; Grimm R; Fu C; Han J; Sheng R; Zeng M
    Eur J Radiol; 2021 Jun; 139():109732. PubMed ID: 33905978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative Recurrence.
    Chong H; Gong Y; Zhang Y; Dai Y; Sheng R; Zeng M
    Acad Radiol; 2023 Jan; 30(1):49-63. PubMed ID: 35562264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
    Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
    World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
    Chen J; Wu Z; Xia C; Jiang H; Liu X; Duan T; Cao L; Ye Z; Zhang Z; Ma L; Song B; Shi Y
    Eur Radiol; 2020 Feb; 30(2):1232-1242. PubMed ID: 31529254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of the Signal Intensity of Gadoxetic Acid-enhanced MR Imaging for Predicting the Efficacy of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma.
    Fujita N; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Morita K; Shirabe K; Koto K; Kubo Y; Oda Y; Honda H
    Magn Reson Med Sci; 2016; 15(1):111-20. PubMed ID: 26346403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical value of serum GPC3 level in predicting recurrence of patients with primary hepatocellular carcinoma].
    Zhang PR; Ma XL; Guo L; Lu RQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):885-890. PubMed ID: 37357208
    [No Abstract]   [Full Text] [Related]  

  • 8. Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI.
    Dong SY; Wang WT; Chen XS; Yang YT; Zhu S; Zeng MS; Rao SX
    Eur Radiol; 2022 Jun; 32(6):4198-4209. PubMed ID: 35079885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Glypican-3 Expression in Hepatocellular Carcinoma by Using IDEAL IQ Magnetic Resonance Imaging.
    Chen R; Bai Y; Liu T; Zhang G; Han Y; Chen L; Gao H; Wei W; Wang M
    Acad Radiol; 2021 Aug; 28(8):e227-e234. PubMed ID: 32540197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
    Kim SS; Kim SH; Song KD; Choi SY; Heo NH
    J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
    Joo I; Kim SY; Kang TW; Kim YK; Park BJ; Lee YJ; Choi JI; Lee CH; Park HS; Lee K; Kim H; Yu E; Kang HJ; Ha SY; Kim JY; Ahn S; Jung ES; Kim BH; Han HS; Lee JM
    Radiology; 2020 Aug; 296(2):335-345. PubMed ID: 32484414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.
    Zhang N; Wu M; Zhou Y; Yu C; Shi D; Wang C; Gao M; Lv Y; Zhu S
    Front Oncol; 2023; 13():1209814. PubMed ID: 37841420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.
    Phongkitkarun S; Limsamutpetch K; Tannaphai P; Jatchavala J
    World J Gastroenterol; 2013 Dec; 19(45):8357-65. PubMed ID: 24363528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection.
    Fu SJ; Qi CY; Xiao WK; Li SQ; Peng BG; Liang LJ
    Surgery; 2013 Sep; 154(3):536-44. PubMed ID: 23601901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and
    Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
    World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting glypican-3 expression in hepatocellular carcinoma: A comprehensive analysis using combined contrast-enhanced ultrasound and clinical factors.
    Li N; Dong T; Wang P; Li Q; Nie F
    Clin Hemorheol Microcirc; 2023; 85(4):407-420. PubMed ID: 37638421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of magnetic resonance imaging based on liver imaging reporting and data system for evaluating phosphatidylinositol proteoglycan-3 expression in hepatocellular carcinoma].
    Sun W; Zhao JT; Gao SS; Han J; Sheng RF; Zeng M
    Zhonghua Gan Zang Bing Za Zhi; 2022 Aug; 30(8):866-872. PubMed ID: 36207943
    [No Abstract]   [Full Text] [Related]  

  • 18. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
    Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
    Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
    Kitao A; Matsui O; Zhang Y; Ogi T; Nakada S; Sato Y; Harada K; Yoneda N; Kozaka K; Inoue D; Yoshida K; Koda W; Yamashita T; Yamashita T; Kaneko S; Kobayashi S; Gabata T
    Radiology; 2023 Feb; 306(2):e220531. PubMed ID: 36219111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
    Chen J; Xia C; Duan T; Cao L; Jiang H; Liu X; Zhang Z; Ye Z; Wu Z; Gao R; Shi Y; Song B
    Eur Radiol; 2021 Oct; 31(10):7696-7704. PubMed ID: 33856520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.